Search
Regulatory Story
Company Consort Medical PLC
TIDM CSRT
Headline Director/PDMR Shareholding
Released 11:08 16-Aug-2019
Number 3385J11

RNS Number : 3385J
Consort Medical PLC
16 August 2019
 

 

Consort Medical plc (the 'Company')

Director/PDMR shareholding

16 August 2019

Consort Medical plc announces that Jonathan Glenn, CEO, has exercised awards over ordinary shares in the Company ('Ordinary Shares') in accordance with the terms of the Consort Medical plc Deferred Bonus Plan (the 'DBP') and the Consort Medical Performance Share Plan (the 'PSP') (together the 'Awards').

The Awards were exercised for nil consideration on 14 August 2019 pursuant to respective awards made on 21 June 2016. 

The exercise of the Awards was satisfied out of the Ordinary Shares held in the Consort Medical plc Employee Share Ownership Trust.

Also on 14 August 2019, Mr Glenn disposed of Ordinary Shares at £7.26 per share with the net proceeds of the disposal used to cover tax liabilities associated to the above exercise of the Awards only.  Mr Glenn's increased resultant interest in the Ordinary Shares of the Company is shown below.

Individual

Director /PDMR

Ordinary Shares exercised under the DBP

Ordinary Shares exercised under the PSP

Total Ordinary Shares exercised

 

Total Ordinary Shares sold

 

Total Ordinary shares retained

Total resultant Ordinary Shares held

% of Ordinary Share capital

held

Jonathan Glenn

Director

19,207

12,510

31,717

14,908

16,809

183,537

0.37

 

The Company was informed of the above transaction by the Consort Medical Employee Share Ownership Trust on 14 August 2019.

Mr Glenn's resultant beneficial shareholding of 183,537 Ordinary Shares equates to 2.6x multiple of his salary (calculated using the exercise share price of £7.26 per share).

Enquiries:    Michelle Palmer Assistant Company Secretary           01442 867920

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Jonathan Glenn

2

Reason for the notification

a)

 

Position/status

 

CEO

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Consort Medical plc

b)

 

LEI

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

1.    Exercise of Deferred Bonus Plan and Performance Share Plan shares

2.    Sale of Deferred Bonus Plan and Performance Share Plan shares to cover the Tax and NI liabilities associated with the exercise of the Awards

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

1.    £0.00

31,717

 


 

2.    £7.26

14,908

 


 

 

 

 

d)

 

Aggregated information



n/a

- Aggregated volume




- Price




e)

 

Date of the transaction

 

14 August 2019

f)

 

Place of the transaction

 

Off market transaction

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBQLFFKVFBBBZ
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.